[1]
Negrini, C. and Psachoulia, E. 2017. Evaluation of the cost saving potential of introducing Benepali® and Flixabi® on the European and Italian markets. Farmeconomia. Health economics and therapeutic pathways. 18, 1 (Oct. 2017). DOI:https://doi.org/10.7175/fe.v18i1.1330.